Oxygenta Pharmaceutical has informed that it enclosed a copy of Detailed Public Statement under Regulations 13(4), 14(3) and 15(2) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended for the attention of the eligible Equity Shareholders of Oxygenta Pharmaceutical (Target Company).
The above information is a part of company’s filings submitted to BSE.